HRS-7415

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameHRS-7415
Drug Alias NameHRS-7415
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphorylation inhibitorsProto-oncogene proteins c-akt inhibitors
TargetsProto-oncogene proteins c-akt
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A